Renal disease following prophylactic inoculation.
D000293:Adolescent; D000328:Adult; D001798:Blood Proteins / Q000032:analysis; D002648:Child; D005260:Female; D005455:Fluorescent Antibody Technique; D005921:Glomerulonephritis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D007117:Immunization, Secondary / Q000009:adverse effects; D007136:Immunoglobulins / Q000032:analysis; D007668:Kidney / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010284:Paratyphoid Fever / Q000517:prevention & control*; D011239:Prednisolone / Q000627:therapeutic use; D006435:Renal Dialysis; D012129:Respiratory Function Tests; D014435:Typhoid Fever / Q000517:prevention & control*; D014436:Typhoid-Paratyphoid Vaccines / Q000009:adverse effects*; D014611:Vaccination / Q000009:adverse effects*
D001798:Blood Proteins; D007136:Immunoglobulins; D014436:Typhoid-Paratyphoid Vaccines; D006493:Heparin; D011239:Prednisolone